Format

Send to

Choose Destination
Neuropathology. 2018 Dec 3. doi: 10.1111/neup.12523. [Epub ahead of print]

Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy.

Author information

1
Department of Neurology, Mifukai Vihara Hananosato Hospital, Hiroshima, Japan.
2
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
3
Department of Neurology and Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital & Institute of Gerontology, Hiroshima, Japan.
4
Department of Neurology, National Hospital Organization Hiroshima-Nishi Medical Center, Hiroshima, Japan.
5
Department of Clinical Laboratory, National Hospital Organization Hiroshima-Nishi Medical Center, Hiroshima, Japan.
6
Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
7
Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.

Abstract

Amyotrophic lateral sclerosis (ALS) primarily affects upper and lower motor neurons. Phosphorylated trans-activation response DNA-binding protein of 43 kDa (TDP-43) inclusion bodies are reportedly a pathological hallmark of sporadic ALS. Here, we present an atypical case of sporadic ALS that progressed very slowly, persisted for 19 years, and clinically appeared to only affect the lower motor neurons; however, upper motor neuron degeneration was detected at autopsy. Furthermore, no inclusion bodies positive for phosphorylated TDP-43, ubiquitin, fused in sarcoma, or superoxide dismutase-1 were detected in the central nervous system. We performed exome-sequencing data analysis but found no genetic disorders. This was therefore an unusual case of lower motor neuron-predominant ALS without TDP-43 pathology or known gene-disease associations. We also reviewed autopsied ALS cases that progressed slowly and had no phosphorylated TDP-43 or ubiquitin-positive inclusions and present the clinicopathological features of such cases. Based on these results, there may be a sporadic ALS subgroup that progresses slowly and shows no accumulation of phosphorylated TDP-43.

KEYWORDS:

TDP-43; amyotrophic lateral sclerosis; autopsy; motor neuron disease; progressive muscular atrophy

PMID:
30511354
DOI:
10.1111/neup.12523

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center